Immunomedics Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
9,041.60
5,653.10
3,233.20
3,091.30
2,156.00
Cost of Goods Sold (COGS) incl. D&A
2,097.20
843.00
1,159.20
1,382.70
1,910.90
Gross Income
6,944.40
4,810.10
2,074.10
1,708.60
245.10
SG&A Expense
42,524.70
51,029.60
61,082.20
80,858.30
141,292.40
EBIT
35,580.20
46,219.50
59,008.10
79,149.70
141,047.30
Unusual Expense
-
-
-
68,723.20
115,003.10
Non Operating Income/Expense
0.90
9.80
37.50
307.30
81.40
Interest Expense
-
2,090.80
5,479.80
5,479.80
23,254.80
Pretax Income
35,523.40
48,065.70
64,189.50
153,245.40
273,731.20
Income Tax
7.80
58.20
5,053.80
20.90
155.80
Consolidated Net Income
35,531.20
48,124.00
59,135.70
153,266.30
273,887.00
Net Income
35,425.80
48,002.40
59,037.00
153,205.90
273,836.90
Net Income After Extraordinaries
35,425.80
48,002.40
59,037.00
153,205.90
273,836.90
Net Income Available to Common
35,425.80
48,002.40
59,037.00
153,205.90
273,836.90
EPS (Basic)
0.42
0.51
0.62
1.47
1.78
Basic Shares Outstanding
84,631.60
93,314.90
94,770.20
104,535.60
153,474.90
EPS (Diluted)
0.42
0.51
0.62
1.47
1.78
Diluted Shares Outstanding
84,631.60
93,314.90
94,770.20
104,535.60
153,474.90
EBITDA
35,010.80
45,641.40
58,270.40
78,249.70
139,750.00
Non-Operating Interest Income
55.90
234.70
335.90
414.60
5,492.60
Minority Interest Expense
105.40
121.60
98.80
60.30
50.10
About Immunomedics
View Profile
